BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30894683)

  • 21. Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.
    Mahlokozera T; Patel B; Chen H; Desouza P; Qu X; Mao DD; Hafez D; Yang W; Taiwo R; Paturu M; Salehi A; Gujar AD; Dunn GP; Mosammaparast N; Petti AA; Yano H; Kim AH
    Nat Commun; 2021 Nov; 12(1):6321. PubMed ID: 34732716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SIX2 Mediates Late-Stage Metastasis via Direct Regulation of
    Oliphant MUJ; Vincent MY; Galbraith MD; Pandey A; Zaberezhnyy V; Rudra P; Johnson KR; Costello JC; Ghosh D; DeGregori J; Espinosa JM; Ford HL
    Cancer Res; 2019 Feb; 79(4):720-734. PubMed ID: 30606720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling.
    Gao H; Teng C; Huang W; Peng J; Wang C
    Int J Mol Sci; 2015 Sep; 16(9):21643-57. PubMed ID: 26370982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Docetaxel promotes cell apoptosis and decreases SOX2 expression in CD133‑expressing hepatocellular carcinoma stem cells by suppressing the PI3K/AKT signaling pathway.
    Zhang X; Shao J; Li X; Cui L; Tan Z
    Oncol Rep; 2019 Feb; 41(2):1067-1074. PubMed ID: 30483804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The roles of the SOX2 protein in the development of esophagus and esophageal squamous cell carcinoma, and pharmacological target for therapy.
    Zhang J; Wang Z; Zhao H; Wei Y; Zhou Y; Zhang S; Zhao J; Li X; Lin Y; Liu K
    Biomed Pharmacother; 2023 Jul; 163():114764. PubMed ID: 37100016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RCC2 Promotes Esophageal Cancer Growth by Regulating Activity and Expression of the Sox2 Transcription Factor.
    Calderon-Aparicio A; Yamamoto H; De Vitto H; Zhang T; Wang Q; Bode AM; Dong Z
    Mol Cancer Res; 2020 Nov; 18(11):1660-1674. PubMed ID: 32801160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOX2 in development and cancer biology.
    Novak D; Hüser L; Elton JJ; Umansky V; Altevogt P; Utikal J
    Semin Cancer Biol; 2020 Dec; 67(Pt 1):74-82. PubMed ID: 31412296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. XIAP Limits Autophagic Degradation of Sox2 and Is A Therapeutic Target in Nasopharyngeal Carcinoma Stem Cells.
    Ji J; Yu Y; Li ZL; Chen MY; Deng R; Huang X; Wang GF; Zhang MX; Yang Q; Ravichandran S; Feng GK; Xu XL; Yang CL; Qiu MZ; Jiao L; Yang D; Zhu XF
    Theranostics; 2018; 8(6):1494-1510. PubMed ID: 29556337
    [No Abstract]   [Full Text] [Related]  

  • 29. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
    Rybak AP; Tang D
    Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex determining region Y-box 2 inhibits the proliferation of colorectal adenocarcinoma cells through the mTOR signaling pathway.
    Liu H; Du L; Wen Z; Yang Y; Li J; Dong Z; Zheng G; Wang L; Zhang X; Wang C
    Int J Mol Med; 2013 Jul; 32(1):59-66. PubMed ID: 23599173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of the HECT E3 ligase UBR5 as a regulator of MYC degradation using a CRISPR/Cas9 screen.
    Schukur L; Zimmermann T; Niewoehner O; Kerr G; Gleim S; Bauer-Probst B; Knapp B; Galli GG; Liang X; Mendiola A; Reece-Hoyes J; Rapti M; Barbosa I; Reschke M; Radimerski T; Thoma CR
    Sci Rep; 2020 Nov; 10(1):20044. PubMed ID: 33208877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ubiquitination of NOTCH2 by DTX3 suppresses the proliferation and migration of human esophageal carcinoma.
    Ding XY; Hu HY; Huang KN; Wei RQ; Min J; Qi C; Tang H; Qin X
    Cancer Sci; 2020 Feb; 111(2):489-501. PubMed ID: 31854042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
    Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
    J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclin G1 expands liver tumor-initiating cells by Sox2 induction via Akt/mTOR signaling.
    Wen W; Han T; Chen C; Huang L; Sun W; Wang X; Chen SZ; Xiang DM; Tang L; Cao D; Feng GS; Wu MC; Ding J; Wang HY
    Mol Cancer Ther; 2013 Sep; 12(9):1796-804. PubMed ID: 23804702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive Exploration to Identify Predictive DNA Markers of ΔNp63/SOX2 in Drug Resistance in Human Esophageal Squamous Cell Carcinoma.
    Ooizumi Y; Kojima K; Igarashi K; Tanaka Y; Harada H; Yokota K; Kaida T; Ishii S; Tanaka T; Yokoi K; Nishizawa N; Washio M; Ushiku H; Katoh H; Kosaka Y; Mieno H; Hosoda K; Watanabe M; Katada C; Hiki N; Yamashita K
    Ann Surg Oncol; 2019 Dec; 26(13):4814-4825. PubMed ID: 31529309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-625 down-regulation promotes proliferation and invasion in esophageal cancer by targeting Sox2.
    Wang Z; Qiao Q; Chen M; Li X; Wang Z; Liu C; Xie Z
    FEBS Lett; 2014 Mar; 588(6):915-21. PubMed ID: 24508466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
    Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
    Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex.
    Gu J; Mao W; Ren W; Xu F; Zhu Q; Lu C; Lin Z; Zhang Z; Chu Y; Liu R; Ge D
    Cancer Lett; 2019 Feb; 443():125-134. PubMed ID: 30503554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
    Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
    J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Galectin-3 modulates the EGFR signalling-mediated regulation of Sox2 expression via c-Myc in lung cancer.
    Kuo HY; Hsu HT; Chen YC; Chang YW; Liu FT; Wu CW
    Glycobiology; 2016 Feb; 26(2):155-65. PubMed ID: 26447186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.